About
Minimally-Invasive Hydrocephalus Treatment
Areas of Focus
Categories
Medical ImplantBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
344
By Phase
NA: 5
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06498960Lead Sponsor
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NARecruiting
230 participants
Started: Nov 26, 2024 · Completed: Jan 1, 2031
NCT05501002Lead Sponsor
Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus
NATerminated
4 participants
Started: Sep 15, 2022 · Completed: Sep 15, 2023
NCT05232838Lead Sponsor
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NAActive, not recruiting
50 participants
Started: Apr 20, 2022 · Completed: Jun 30, 2030
NCT05250505Lead Sponsor
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NAActive, not recruiting
30 participants
Started: Mar 10, 2022 · Completed: Apr 30, 2027
NCT04758611Lead Sponsor
The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)
NARecruiting
30 participants
Started: Oct 1, 2020 · Completed: Dec 1, 2027
Funding History (1)
D
Jun 5, 2020
Locations (1)
Headquarters
Charlestown, MA, United States
Map
Loading map...